samples/Outcome-Predictors-leaderboard.csv

,Round,TCGAID,MajorAxisLength,MinorAxisLength,PropnCET,T1FLAIR,nCETCrossMidline,rCBVmean,rCBVmax,rCBVfl,Machine,Subtype_by_phils,Subtype_by_Verhaak,age_at_initial_pathologic_diagno,date_of_initial_pathologic_diagn,days_to_birth,days_to_death,days_to_last_followup,ethnicity,gender,histological_type,karnofsky_performance_score,performance_status_scale_timing,person_neoplasm_cancer_status,prior_glioma,race,tumor_histologic_subtype,tumor_tissue_site,vital_status,days_to_tumor_recurrence,time_to_progression,progEvent,progSurvTime,OStime,rCBVmeanSD,rCBVmaxSD,rCBVflSD,rCBVmean2,rCBVmax2,rCBVfl2,age5,cohort,gcimp,egfrAmp,pdgfraAmp,ptenAmp,egfrMut,ptenMut,sequenced,Extent_of_Resection
0,1,TCGA-06-0122,71.47023114,40.43448767,None (0%),Mixed T1<FLAIR Ratio,Crosses Midline No,6.86,9.483,1.467,3T,Mes,Mesenchymal,84,2006-00-00,-30967,181,8,NOT HISPANIC OR LATINO,FEMALE,,,,,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,181,181,7.0280743631,4.8061079943,2.9471538976,high,high,high,16.8,6,NEG,2.0,0.0,-1.0,,,1,STR
1,1,TCGA-06-0127,86.97233129,55.44624428,6-33%,Mixed T1<FLAIR Ratio,Crosses Midline Yes,4.243,5.973,1.177,1.5T,PN,Neural,67,2002-00-00,-24502,121,108,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,60.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,90.0,1,90,121,4.3469561986,3.0271942476,2.3645536043,high,high,high,13.4,2,NEG,2.0,0.0,-1.0,"V292L,V292L,V292L",,1,STR
2,2,TCGA-06-0128,68.54275415,55.25454465,34-67%,Expansive T1~FLAIR Ratio,Crosses Midline No,1.388,2.83,0.713,1.5T,PN,Proneural,66,2000-00-00,-24217,691,691,NOT HISPANIC OR LATINO,MALE,,80.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,189.0,1,189,691,1.4220068828,1.4342808841,1.432393135,low,low,low,13.2,0,POS,0.0,0.0,-1.0,,,1,GTR
3,1,TCGA-06-0132,90.38251662,62.26697312,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.173,6.127,0.837,1.5T,PN,Neural,49,2007-00-00,-18125,761,570,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,482.0,1,482,761,2.2262398821,3.1052434547,1.6815049845,low,high,high,9.8,7,NEG,2.0,0.0,-1.0,,,1,STR
4,1,TCGA-06-0133,102.8050346,62.89969015,34-67%,Mixed T1<FLAIR Ratio,Crosses Midline Yes,2.435,4.663,0.553,3T,PN,Neural,64,2007-00-00,-23402,435,428,NOT HISPANIC OR LATINO,MALE,,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,78.0,1,78,435,2.4946590487,2.363269174,1.1109584904,high,high,low,12.8,7,NEG,2.0,0.0,-1.0,,,1,STR
5,1,TCGA-06-0137,101.8218393,56.31768036,None (0%),Mixed T1<FLAIR Ratio,Crosses Midline No,2.53,4.317,0.717,1.5T,Mes,Classical,63,2003-00-00,-23273,812,701,NOT HISPANIC OR LATINO,FEMALE,,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,487.0,1,487,812,2.5919866091,2.1879118645,1.4404290011,high,low,low,12.6,3,NEG,2.0,0.0,-1.0,P596L,,1,STR
6,1,TCGA-06-0139,80.6709788,39.04821797,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.112,4.497,1.24,3T,Mes,Mesenchymal,40,2006-00-00,-14728,383,327,NOT HISPANIC OR LATINO,MALE,,60.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,152.0,1,152,383,2.1637453433,2.2791382105,2.4911184956,low,high,high,8.0,6,NEG,1.0,0.0,-1.0,,,1,STR
7,1,TCGA-06-0143,114.8301745,65.62670418,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline Yes,2.393,5.657,0.353,3T,Mes,Mesenchymal,58,2006-00-00,-21386,357,357,NOT HISPANIC OR LATINO,MALE,,60.0,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,264.0,264.0,1,264,357,2.451630022,2.8670413291,0.7091651846,low,high,low,11.6,6,NEG,2.0,2.0,-1.0,,,1,STR
8,1,TCGA-06-0147,74.49334479,51.14346067,None (0%),Expansive T1~FLAIR Ratio,Crosses Midline No,2.24,4.76,0.865,1.5T,Mes,Mesenchymal,51,1999-00-00,-18742,541,508,NOT HISPANIC OR LATINO,FEMALE,,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,92.0,1,92,541,2.2948814247,2.4124300383,1.7377560473,low,high,high,10.2,-1,NEG,1.0,0.0,-1.0,,,1,STR
9,1,TCGA-06-0149,90.87360905,48.56049078,68-95%,Infiltrative T1<<FLAIR Ratio,Crosses Midline Yes,2.51,3.99,2.057,3T,Mes,Mesenchymal,74,2005-00-00,-27315,262,238,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,80.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,203.0,1,203,262,2.5714965964,2.0221840027,4.1324441495,high,low,high,14.8,5,NEG,1.0,0.0,-1.0,,,0,STR
10,1,TCGA-06-0164,66.76339735,46.13628674,None (0%),Expansive T1~FLAIR Ratio,Crosses Midline No,1.768,4.363,0.607,1.5T,Mes,Mesenchymal,47,2000-00-00,-17510,1730,1729,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,100.0,Pre-Operative,WITH TUMOR,NO,ASIAN,Glioblastoma multiforme,BRAIN,DECEASED,,1428.0,1,1428,1730,1.8113171245,2.2112252641,1.2194426829,low,low,low,9.4,0,NEG,1.0,0.0,-1.0,,,0,GTR
11,1,TCGA-06-0166,79.76086734,74.46603485,< 5%,Mixed T1<FLAIR Ratio,Crosses Midline No,3.038,4.47,0.763,1.5T,PN,Proneural,51,2001-00-00,-18902,178,161,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,66.0,1,66,178,3.1124329322,2.2654542586,1.5328414614,high,low,high,10.2,1,NEG,1.0,2.0,-1.0,,"T167S,T167S",1,STR
12,1,TCGA-06-0168,44.13221598,24.29751635,6-33%,Infiltrative T1<<FLAIR Ratio,Crosses Midline No,1.37,3.303,0.62,1.5T,Mes,Neural,59,2002-00-00,-21776,598,579,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,100.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,461.0,1,461,598,1.4035658713,1.6740034488,1.2455592478,low,low,low,11.8,2,NEG,1.0,0.0,-1.0,,A328fs,1,STR
13,1,TCGA-06-0173,107.1367651,52.88218154,6-33%,Infiltrative T1<<FLAIR Ratio,Crosses Midline Yes,2.027,3.73,0.96,3T,Prolif,Neural,72,2003-00-00,-26548,171,7,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,171,171,2.0766627892,1.890412614,1.9286078676,low,low,high,14.4,3,NEG,2.0,2.0,-1.0,,,1,STR
14,1,TCGA-06-0175,58.76606943,37.35171235,None (0%),Infiltrative T1<<FLAIR Ratio,Crosses Midline No,2.12,3.63,0.577,1.5T,Mes,Mesenchymal,69,2003-00-00,-25558,123,83,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,100.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,39.0,1,39,123,2.1719413484,1.8397313107,1.1591736871,low,low,low,13.8,3,NEG,1.0,0.0,-1.0,,,0,GTR
15,1,TCGA-06-0177,70.2938662,47.73769856,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,1.368,3.067,0.253,1.5T,Prolif,Proneural,64,2004-00-00,-23498,127,60,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,60.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,127,127,1.4015168701,1.554395573,0.5082685318,low,low,low,12.8,4,NEG,2.0,2.0,-1.0,,,0,STR
16,1,TCGA-06-0179,64.06461812,44.22389414,< 5%,Mixed T1<FLAIR Ratio,Crosses Midline No,2.51,5.493,0.623,3T,PN,Neural,64,2004-00-00,-23449,616,578,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,60.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,250.0,1,250,616,2.5714965964,2.7839239916,1.2515861474,high,high,low,12.8,4,NEG,2.0,0.0,-1.0,,,0,GTR
17,1,TCGA-06-0184,82.84546219,64.92510487,6-33%,Expansive T1~FLAIR Ratio,Crosses Midline No,1.672,3.067,0.71,1.5T,Mes,Mesenchymal,63,2005-00-00,-23317,2126,1228,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,1276.0,1,1276,2126,1.7129650634,1.554395573,1.4263662354,low,low,low,12.6,5,NEG,1.0,0.0,-1.0,,"G36E,G36E,G36E",1,GTR
18,1,TCGA-06-0185,72.07177397,44.71617175,6-33%,Mixed T1<FLAIR Ratio,Crosses Midline No,1.99,4.267,0.413,1.5T,PN,Neural,54,2005-00-00,-19922,2366,2246,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,100.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,711.0,1,711,2366,2.0387562657,2.1625712129,0.8297031764,low,low,low,10.8,5,NEG,2.0,0.0,-2.0,"V651M,V651M,V651M",,1,GTR
19,1,TCGA-06-0187,65.87112795,44.41677325,None (0%),Expansive T1~FLAIR Ratio,Crosses Midline No,1.835,3.233,0.517,1.5T,Mes,Classical,69,2006-00-00,-25317,828,801,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,60.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,531.0,531.0,1,531,828,1.8799586671,1.6385265365,1.0386356953,low,low,low,13.8,6,NEG,2.0,0.0,-1.0,,"G132D,G132D,G132D",1,STR
20,2,TCGA-06-0189,85.25564146,56.4416166,< 5%,Mixed T1<FLAIR Ratio,Crosses Midline No,2.708,4.99,0.573,3T,Mes,Mesenchymal,55,2006-00-00,-20296,468,454,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,468,468,2.7743477223,2.5289970359,1.1511378209,high,high,low,11.0,6,NEG,2.0,0.0,-1.0,,,1,STR
21,2,TCGA-06-0190,74.76880933,60.24171094,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,4.376,6.68,1.333,1.5T,Mes,Mesenchymal,62,2006-00-00,-22835,317,313,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,88.0,1,88,317,4.4832147832,3.3855110621,2.6779523828,high,high,high,12.4,6,NEG,1.0,1.0,-1.0,,"D92E,D92E,D92E",1,STR
22,1,TCGA-06-0192,79.16025289,42.82469307,6-33%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.425,4.16,1.22,3T,Mes,Mesenchymal,58,2007-00-00,-21243,1185,556,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,100.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,648.0,1,648,1185,2.4844140423,2.1083422183,2.450939165,high,low,high,11.6,7,NEG,2.0,2.0,-1.0,,Y315*,1,GTR
23,1,TCGA-06-0213,72.9466112,43.71555926,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.167,3.763,0.767,1.5T,Mes,Mesenchymal,55,1998-00-00,-20134,16,6,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,16,16,2.2200928782,1.9071374441,1.5408773275,low,low,high,11.0,-2,NEG,1.0,0.0,-2.0,,"R335*,R335*",1,STR
24,1,TCGA-06-0237,70.35187771,28.66265438,68-95%,Infiltrative T1<<FLAIR Ratio,Crosses Midline No,3.365,5.537,0.613,1.5T,PN,Neural,75,2006-00-00,-27735,415,314,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,415,415,3.4474446402,2.8062237651,1.2314964821,high,high,low,15.0,6,NEG,2.0,1.0,-1.0,"L62R,L62R",,1,STR
25,2,TCGA-06-0238,76.80296366,48.00510283,6-33%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.346,4.023,0.62,3T,PN,Proneural,46,2007-00-00,-17037,405,359,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,311.0,1,311,405,2.4034784921,2.0389088328,1.2455592478,low,low,low,9.2,7,NEG,1.0,0.0,-1.0,,,1,STR
26,1,TCGA-06-0241,53.7870232,33.79282207,None (0%),Mixed T1<FLAIR Ratio,Crosses Midline No,2.912,4.43,0.66,3T,Prolif,Proneural,65,2007-00-00,-24101,1481,455,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,100.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,196.0,196.0,1,196,1481,2.9833458521,2.2451817373,1.3259179089,high,low,low,13.0,7,NEG,1.0,2.0,-1.0,,,1,STR
27,1,TCGA-06-0644,51.55889274,40.19048554,None (0%),Expansive T1~FLAIR Ratio,Crosses Midline No,2.555,4.19,0.617,3T,Mes,Mesenchymal,71,2007-00-00,-26246,384,375,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Operative,WITH TUMOR,NO,BLACK OR AFRICAN AMERICAN,Glioblastoma multiforme,BRAIN,DECEASED,85.0,85.0,1,85,384,2.617599125,2.1235466093,1.2395323482,high,low,low,14.2,7,NEG,1.0,0.0,-1.0,,"T202fs,I203fs",1,STR
28,1,TCGA-06-0646,47.0471611,36.60848593,34-67%,Expansive T1~FLAIR Ratio,Crosses Midline No,3.393,4.86,1.033,3T,Mes,Proneural,60,2007-00-00,-22272,175,136,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,90.0,1,90,175,3.476130658,2.4631113416,2.0752624241,high,high,high,12.0,7,NEG,2.0,1.0,-2.0,,,1,STR
29,1,TCGA-06-0648,89.38226471,60.540485,6-33%,Expansive T1~FLAIR Ratio,Crosses Midline No,1.925,4.0,0.76,3T,PN,Proneural,77,2007-00-00,-28477,298,293,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Operative,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,201.0,1,201,298,1.9721637243,2.027252133,1.5268145618,low,low,high,15.4,7,NEG,1.0,0.0,-1.0,,,1,STR
30,1,TCGA-08-0352,115.0557228,66.04929696,< 5%,Mixed T1<FLAIR Ratio,Crosses Midline No,2.752,5.727,0.56,1.5T,Mes,Mesenchymal,79,2003-00-00,-29106,39,39,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,39,39,2.8194257503,2.9025182414,1.1250212561,high,high,low,15.8,3,NEG,2.0,0.0,-1.0,,K263*,1,
31,1,TCGA-08-0353,79.35522434,44.92923295,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.748,4.98,0.94,1.5T,Prolif,Proneural,58,2003-00-00,-21332,256,195,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Post-Adjuvant Therapy,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,164.0,1,164,256,2.8153277478,2.5239289056,1.888428537,high,high,high,11.6,3,NEG,,,,,,1,
32,1,TCGA-08-0354,53.97760228,38.37069558,34-67%,Expansive T1~FLAIR Ratio,Crosses Midline Yes,3.038,5.393,0.827,1.5T,Mes,Classical,52,2003-00-00,-19198,546,458,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,60.0,Post-Adjuvant Therapy,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,253.0,1,253,546,3.1124329322,2.7332426883,1.6614153192,high,high,high,10.4,3,NEG,2.0,0.0,-1.0,,,1,
33,1,TCGA-08-0355,77.67814706,56.93133533,6-33%,Expansive T1~FLAIR Ratio,Crosses Midline No,3.073,5.27,0.463,1.5T,Mes,Classical,30,2003-00-00,-11098,747,685,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,100.0,Other,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,519.0,519.0,1,519,747,3.1482904545,2.6709046852,0.9301515028,high,high,low,6.0,3,,2.0,0.0,-1.0,A289D,,1,
34,1,TCGA-08-0356,67.52694124,38.67870135,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.058,4.89,0.273,1.5T,Mes,Classical,59,2004-00-00,-21900,946,447,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,80.0,Pre-Adjuvant Therapy,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,447.0,447.0,1,447,946,2.1084223089,2.4783157326,0.5484478623,low,high,low,11.8,4,NEG,2.0,0.0,-1.0,,,1,
35,1,TCGA-08-0357,65.42796422,41.479033,6-33%,Mixed T1<FLAIR Ratio,Crosses Midline No,2.972,4.567,1.01,1.5T,PN,Classical,49,2004-00-00,-18143,1143,1084,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Other,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,155.0,155.0,1,155,1143,3.0448158902,2.3146151229,2.029056194,high,high,high,9.8,4,NEG,2.0,0.0,-1.0,,,1,
36,1,TCGA-08-0358,62.85813516,42.12099332,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.968,4.8,0.473,1.5T,PN,Classical,50,2005-00-00,-18383,678,593,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Adjuvant Therapy,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,263.0,263.0,1,263,678,3.0407178877,2.4327025596,0.9502411681,high,high,low,10.0,5,NEG,2.0,0.0,-1.0,,,1,
37,1,TCGA-08-0359,57.70535869,53.43134242,6-33%,Mixed T1<FLAIR Ratio,Crosses Midline Yes,1.518,3.413,0.933,1.5T,PN,Proneural,59,2005-00-00,-21748,102,29,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,102,102,1.5551919655,1.7297528825,1.8743657713,low,low,high,11.8,5,NEG,,,,,"R47G,R47G",1,
38,1,TCGA-08-0360,33.67883942,25.59985695,6-33%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.252,3.993,0.587,1.5T,Mes,Mesenchymal,76,2005-00-00,-27894,468,352,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Pre-Adjuvant Therapy,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,112.0,112.0,1,112,468,2.3071754323,2.0237044418,1.1792633523,low,low,low,15.2,5,NEG,,,,,,1,
39,1,TCGA-08-0385,77.56004839,55.03851551,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,2.546,16.267,1.125,1.5T,PN,Proneural,71,2003-00-00,-26233,82,31,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,60.0,Pre-Adjuvant Therapy,WITH TUMOR,NO,,Glioblastoma multiforme,BRAIN,DECEASED,,,1,82,82,2.6083786193,8.2443276119,2.2600873448,high,high,high,14.2,3,,,,,,,1,
40,1,TCGA-08-0389,62.87975086,36.42895664,68-95%,Mixed T1<FLAIR Ratio,Crosses Midline No,1.862,3.317,1.123,1.5T,PN,Proneural,59,2005-00-00,-21638,467,97,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,80.0,Other,WITH TUMOR,NO,,Glioblastoma multiforme,BRAIN,DECEASED,,,1,467,467,1.9076201843,1.6810988313,2.2560694117,low,low,high,11.8,5,NEG,1.0,0.0,-1.0,,F271S,1,
41,1,TCGA-08-0392,96.34986554,56.55214654,< 5%,Expansive T1~FLAIR Ratio,Crosses Midline No,1.728,3.923,0.457,1.5T,Prolif,Mesenchymal,60,2005-00-00,-22056,22,9,NOT HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,,,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,,1,22,22,1.770337099,1.9882275294,0.9180977036,low,low,low,12.0,5,NEG,1.0,0.0,-1.0,,,0,
42,1,TCGA-08-0521,71.92146975,45.32140912,None (0%),Mixed T1<FLAIR Ratio,Crosses Midline No,1.74,4.72,1.017,1.5T,Mes,Mesenchymal,17,2002-00-00,-6376,146,146,HISPANIC OR LATINO,MALE,Untreated primary (de novo) GBM,60.0,Post-Adjuvant Therapy,WITH TUMOR,NO,BLACK OR AFRICAN AMERICAN,Glioblastoma multiforme,BRAIN,DECEASED,,125.0,1,125,146,1.7826311067,2.3921575169,2.0431189597,low,high,high,3.4,2,NEG,2.0,0.0,-1.0,,,0,
43,1,TCGA-08-0524,114.4584859,58.49940496,6-33%,Mixed T1<FLAIR Ratio,Crosses Midline Yes,2.216,5.003,1.103,1.5T,PN,Proneural,17,2002-00-00,-6464,220,198,NOT HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,80.0,Other,WITH TUMOR,NO,WHITE,Glioblastoma multiforme,BRAIN,DECEASED,,61.0,1,61,220,2.2702934094,2.5355856054,2.2158900812,low,high,high,3.4,2,NEG,0.0,2.0,0.0,,,0,
44,1,TCGA-08-0529,70.00860426,43.9033772,None (0%),Expansive T1~FLAIR Ratio,Crosses Midline No,4.313,5.373,0.8,1.5T,Mes,Classical,56,2004-00-00,-20556,559,526,HISPANIC OR LATINO,FEMALE,Untreated primary (de novo) GBM,80.0,Pre-Adjuvant Therapy,WITH TUMOR,NO,,Glioblastoma multiforme,BRAIN,DECEASED,328.0,328.0,1,328,559,4.4186712431,2.7231064277,1.607173223,high,high,high,11.2,4,NEG,2.0,0.0,-1.0,,,0,